LLMs like Chat GPT come with major social costs — including child labor — that we can’t ignore. Do we really need progress that’s built on the suffering of others?

“The advancements in AI and robotics will bring us to the point where working is optional,” billionaire Tesla CEO Elon Musk says.

As healthcare providers increasingly adopt artificial intelligence tools, researchers, physicians and health tech companies are moving quickly to assess the verifiable impact of these technologies. | An Elation Health survey found that 76% of clinicians believe AI features are helping them provide better care, with 61% saying it is reducing stress or burnout.

Analysts will be watching to see if Thrive-owned firms actually succeed in building long-term profitable businesses using OpenAI’s tech, or if the result is really just pumped up valuations based on speculative market potential. 

The $2 billion investment in Synopsys, which makes software and components for designing semiconductor chips, deepens their existing partnership at a time when analysts scrutinize circular AI-industry deals and warn of a potential bubble.

On Black Friday, Amazon sessions that resulted in a sale were up 100% in the U.S. when the AI chatbot Rufus was used. They only increased by 20% when Rufus wasn’t used.

The Financial Times Group has announced a strategic partnership with RavenPack, a leader in artificial intelligence and big data analytics for financial services. Terms were not disclosed The partnership comprises three components: an investment in RavenPack by FT Ventures, an AI content license framework with FT Professional, and access to selected FT Group products and services. […]

The NIH funding will help BioInVision and university researchers develop technology to track “hiding” cells throughout the body.

You may want to consider buying this not-so-obvious AI stock on its recent 20% pullback.